MEI Pharma Statistics Share Statistics MEI Pharma has 6.66M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 6.66M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) 2.19% Shares Floating 5.71M Failed to Deliver (FTD) Shares 229,864 FTD / Avg. Volume 14.99%
Short Selling Information The latest short interest is 2.64M, so 8.04% of the outstanding
shares have been sold short.
Short Interest 2.64M Short % of Shares Out 8.04% Short % of Float 8.34% Short Ratio (days to cover) 7.2
Valuation Ratios The PE ratio is 1.07 and the forward
PE ratio is -0.83.
MEI Pharma's PEG ratio is
-0.01.
PE Ratio 1.07 Forward PE -0.83 PS Ratio 0.29 Forward PS 0.8 PB Ratio 0.58 P/FCF Ratio -0.38 PEG Ratio -0.01
Financial Ratio History Enterprise Valuation MEI Pharma has an Enterprise Value (EV) of 15.28M.
EV / Sales 0.23 EV / EBITDA 0.84 EV / EBIT -0.3 EV / FCF -0.3
Financial Position The company has a current ratio of 4.88,
with a Debt / Equity ratio of 0.
Current Ratio 4.88 Quick Ratio 4.88 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is 53.84% and Return on Invested Capital is 44.04%.
Return on Equity 53.84% Return on Assets 42.97% Return on Invested Capital 44.04% Revenue Per Employee $2.33M Profits Per Employee $634.93K Employee Count 28 Asset Turnover 1.58 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 7.34% in the
last 52 weeks. The beta is 0.22, so MEI Pharma's
price volatility has been higher than the market average.
Beta 0.22 52-Week Price Change 7.34% 50-Day Moving Average 4.55 200-Day Moving Average 2.94 Relative Strength Index (RSI) 29.66 Average Volume (20 Days) 1,533,477
Income Statement In the last 12 months, MEI Pharma had revenue of 65.3M
and earned 17.78M
in profits. Earnings per share was 2.67.
Revenue 65.3M Gross Profit 64.91M Operating Income 14.54M Net Income 17.78M EBITDA 18.16M EBIT 26M Earnings Per Share (EPS) 2.67
Full Income Statement Balance Sheet The company has 3.71M in cash and 0 in
debt, giving a net cash position of 3.71M.
Cash & Cash Equivalents 3.71M Total Debt n/a Net Cash n/a Retained Earnings -388.22M Total Assets 20.78M Working Capital 19.54M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -50.47M
and capital expenditures -7K, giving a free cash flow of -50.48M.
Operating Cash Flow -50.47M Capital Expenditures -7K Free Cash Flow -50.48M FCF Per Share -7.58
Full Cash Flow Statement Margins Gross margin is 99.41%, with operating and profit margins of 22.27% and 27.23%.
Gross Margin 99.41% Operating Margin 22.27% Pretax Margin 27.23% Profit Margin 27.23% EBITDA Margin 27.81% EBIT Margin 22.27% FCF Margin -77.31%
Dividends & Yields MEIP does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield 93.62% FCF Yield -265.83%
Dividend Details Analyst Forecast Currently there are no analyst rating for MEIP.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number 17.25 Graham Upside 461.89%
Stock Splits The last stock split was on Apr 17, 2023. It was a
backward
split with a ratio of 1:20.
Last Split Date Apr 17, 2023 Split Type backward Split Ratio 1:20
Scores Altman Z-Score -17.45 Piotroski F-Score 1
